.jpg)
STAT Plus: Pharmalittle: Biden getting more pharma donations than Trump; FDA safety plan not ‘well suited’ for opioids
Good morning, everyone, and nice to be back after an extended weekend break. Nonetheless, time…
Category: drug pricing
STAT Plus: Drug industry CEOs will testify this week about some of pharma’s most controversial medicines
The House Oversight Committee will hold two days of hearings this week with six drug…
STAT Plus: With a new law, California becomes the first state to pursue its own line of generics
In a groundbreaking move, California adopted a law Monday to allow the state to develop…
Republicans blasted Obama’s use of an obscure Medicare law. Now Trump’s using it on $200 drug coupons — and the GOP is silent
WASHINGTON — The last time a president used an obscure law to spend billions of…
Opinion: Personalized medicine is the future of health care. Two Trump administration proposals could stymie it
“It is more important to know what kind of patient the disease has than to…
Trump promises seniors $200 prescription drug gift certificates, but questions abound
WASHINGTON — President Trump on Thursday pledged to send $200 prescription drug coupons to 33…
STAT Plus: Gilead to pay $97 million for allegedly using a charity to pay kickbacks to Medicare patients
Gilead Sciences (GILD) agreed to pay nearly $97 million to resolve allegations that donations it…
STAT Plus: HHS criticizes Lilly for seeking to curtail discounts for safety-net hospitals
In a stern rebuke, the Department of Health and Human Services has taken Eli Lilly…
STAT Plus: Public funding underwrote much of the development of J&J’s drug for TB, analysis finds
Amid ongoing debate over taxpayer dollars used to generate medicines, a new analysis contends that…
STAT Plus: Novartis sells bonds tied to expanding access to medicines in poor countries
In a first-of-its-kind move by a large drug maker, Novartis (NVS) raised approximately $2.1 billion…
State treasurers urge Gilead to lower the price of remdesivir and not pursue “unreasonable profits”
Nearly a dozen state treasurers are asking Gilead Sciences (GILD) to lower the price of…
STAT Plus: Biden-aligned group outlines potential Day 1 drug pricing actions
WASHINGTON — A leading think tank aligned with the Democratic Party is laying the groundwork…
STAT Plus: The cost of Gilead’s HIV prevention pill thwarted widespread use, study finds
The escalating cost of the only HIV prevention pill may have been a key factor…
Opinion: Trump’s ‘most favored nation’ executive order on drug prices is a scam for seniors
The White House announced a most favored nations executive order on Sunday, its latest attempt…
STAT Plus: Lawmakers demand drug makers stop threatening to end discounts for safety-net hospitals
Dozens of U.S. lawmakers sent sharply worded letters to the Trump administration and the pharmaceutical…
Trump’s last-ditch drug pricing moves could help him in November. But they likely won’t save Americans money
WASHINGTON — With 50 days to go before the 2020 election, President Trump is taking…
With election looming, Trump releases major, last-ditch drug pricing order
WASHINGTON — President Trump released an executive order Sunday that would drastically cut how much…
STAT Plus: A Pennsylvania lawmaker wants to tie prescription drug prices to what Canada pays
In the latest gambit by a state lawmaker to lower prescription drug costs, a Pennsylvania…
Opinion: Instead of eliminating drug rebates, use average sales price to set co-insurance levels
Changing key elements of the U.S. health care system can be effective and in the…
STAT Plus: Pharmalittle: States asked to speed Covid-19 vaccine distribution sites; NIH panel contradicts FDA on plasma
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT Plus: How Trump could use a rare regulatory maneuver to lower drug prices before Election Day, and how it could backfire
WASHINGTON — The final two months before a presidential election don’t typically feature much policymaking,…
STAT Plus: Congressional committee to subpoena AbbVie in drug pricing investigation
A Congressional committee plans to subpoena AbbVie (ABBV) for documents about pricing practices for two…
STAT Plus: Mylan launches a low-cost biosimilar insulin, but experts say many patients may not save on costs
Amid a national outcry over the cost of insulin, one of the largest generic companies…
STAT Plus: New poll shows wide support for several Trump drug pricing reforms, but not rebate changes
WASHINGTON — Voters in several battleground states overwhelmingly support several of President Trump’s recent proposals…
STAT Plus: Employers are planning how to blunt the cost of pricey new specialty drugs
As the pharmaceutical industry develops increasingly expensive medicines – notably, those costing seven figures –…
STAT Plus: Pharmalittle: Covid-19 vaccine makers push EU for liability protections; pharma plans counteroffer to Trump
Good morning, everyone, and how are you today? Another busy day is unfolding here on…
STAT Plus: Drug industry lobbyists circulate two drug pricing proposals in hopes of warding off a Trump executive order
WASHINGTON — The pharmaceutical industry is weighing two drug pricing policies that it could offer…
PhRMA scrambles to respond to Trump’s drug pricing ultimatum, as Monday deadline looms
WASHINGTON — Drug makers and their lobbyists are struggling to agree on a strategy that…
STAT Plus: Drug makers seek to curtail discounts paid to hospitals as part of a controversial federal program
A growing number of drug makers are taking steps to curtail the discounts they offer…
STAT Plus: Federal prosecutors allege Teva used charities to pay kickbacks to Medicare patients
Federal authorities alleged that Teva Pharmaceuticals (TEVA) donated hundreds of millions of dollars to a…
Trump campaign’s Facebook ad blitz casts Biden as pharma’s preferred candidate
WASHINGTON — President Trump’s reelection campaign is appealing to swing voters by attacking “Big Pharma”…
STAT Plus: Medicaid beneficiaries sue Texas health agency for restricting access to hepatitis C medicines
A group of Medicaid enrollees is accusing a Texas agency of rationing hepatitis C medicines…
STAT Plus: Many psoriasis patients are paying higher prices than ever at the pharmacy counter
Over the past decade, wholesale prices for self-administered psoriasis medicines rose substantially, underscoring the ongoing…
STAT Plus: Out-of-pocket spending on specialty drugs dropped dramatically after states capped costs
Amid efforts to blunt rising medicines costs, a new analysis finds three states succeeded in…
STAT Plus: AAMC, the medical school trade association, gave $500,000 to dark-money group in 2018
WASHINGTON — The dark-money group Citizens for Truth in Drug Pricing, which has run several…
STAT Plus: Italy becomes first country to require pharma to disclose public funding for R&D costs
Amid growing clamor for more transparency from the pharmaceutical industry, Italy has become the first…
Trump to order government to buy certain drugs solely from U.S. factories, setting up major shakeup for industry
WASHINGTON — President Trump will sign an executive later today directing the federal government to…
STAT Plus: Scientists are testing pricey rare-disease drugs as Covid-19 treatments. What if one works?
Some of the existing drugs scientists are testing as Covid-19 treatments have a special status…
STAT Plus: State attorneys general urge HHS to sidestep Gilead patents to increase remdesivir access
A bipartisan group of state attorneys general is urging the federal government to sidestep the…
STAT Plus: Prescription drugs may be more affordable than you think — unless you pay cash
Amid growing complaints that many Americans cannot afford their prescription medicines, most people in the…
STAT Plus: The drug industry’s new tactic in Washington: calling Trump’s bluff
WASHINGTON — The pharmaceutical industry has sparred with President Trump for four years over drug…
STAT Plus: Seeking to battle high drug prices and the opioid crisis, two states ponder banning gifts to doctors
Over the past month, lawmakers in two states have introduced bills that would ban drug…
.jpg)
STAT Plus: Pharmalittle: Global supply chain not ready for Covid-19 vaccines; Moderna may price its vaccine at up to $60
Good morning, everyone, and welcome to the middle of the week. You made it this…
STAT Plus: Better than the rest or behind the competition? Moderna’s future hinges on how its Covid-19 vaccine fares
Among the pharmaceutical companies closest to developing a Covid-19 vaccine, none has more riding on…
STAT Plus: Lawmakers urge federal watchdog to probe government’s role in discovering remdesivir
Amid concerns over access to medicines that were hatched with U.S. taxpayer funds, Democratic lawmakers…
STAT Plus: Pharmalittle: Pharma execs nix meeting with Trump; Kodak wins big U.S. loan to fix medical supply chain
Hello, everyone, and how are you today? We are doing reasonably well, given the circumstances….
The first U.S. Covid-19 case was found in her district. A congresswoman reflects on the last six months
Six months ago, the first Covid-19 case was diagnosed in the U.S. in a man…
STAT Plus: New York panel seeks extra Medicaid rebates from Biogen for pricey rare disease drug
A New York State panel has recommended that officials seek a supplemental Medicaid rebate for…
Trump administration unveils four executive orders aimed at lowering drug prices
WASHINGTON — The Trump administration unveiled four executive orders on Friday aimed at bringing down…
STAT Plus: Pharmalittle: NIH launching ‘flurry’ of Covid-19 treatment trials; Pfizer-BioNTech deal sets ceiling for vaccine price
Good morning. Elizabeth Cooney here, filling in for Ed Silverman until he returns from vacation…